NIH Change to the Resubmission Policy

The National Center for Advancing Translational Sciences (NCATS) is now accepting proposals to collaborate with its Bridging Interventional Development Gaps (BrIDGs) and Therapeutics for Rare and Neglected Diseases (TRND) program scientists.

BrIDGs scientists collaborate with researchers to advance candidate therapeutics for both common and rare diseases into clinical testing. TRND researchers and their collaborators move new therapeutic candidates through pre-clinical testing, from lead optimization to submission of an investigational new drug application. 

More information:

Read the full announcement
Learn how to collaborate with BrIDGs
Learn how to collaborate with TRND

Image caption: 

Image source: